Monumental Financial Group Inc. Abb Vie Inc. Transaction History

Monumental Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $46,275 - $53,292	320 New	320 $51,000
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $44,038 - $55,987	-320 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $42,233 - $52,400	320 New	320 $52,000
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $100,016 - $113,533	-940 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $98,897 - $110,177	940 New	940 $106,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Monumental Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Monumental Financial Group Inc. with notifications on news.